2'5' oligo(A) polymerase activity in serum of mice infected with EMC virus or treated with interferon

Nature
|June 12, 1980
PubMed

Insights

Interferon treatment activates enzymes that produce 2'5'-oligo(A) (2-5A). This study detects 2-5A synthesis in mouse tissues and serum after viral infection or interferon induction.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • Interferon treatment in cells increases dsRNA-dependent enzymatic activity.
  • Oligoadenylate polymerase synthesizes 2'5'-oligo(A) (2-5A) from ATP.
  • 2-5A activates an endoribonuclease that degrades RNA.

Purpose of the Study:

  • To investigate 2-5A synthesis in animal models with elevated interferon levels.
  • To determine if 2-5A synthesis occurs in vivo in response to viral infection.

Main Methods:

  • Mice were infected with encephalomyocarditis virus (EMCV) or treated with interferon inducers.
  • Tissue homogenates and serum were analyzed for 2-5A synthesis.
  • Enzymatic activities were measured in spleen, lungs, and serum.

Main Results:

  • Significant 2-5A synthesis was detected in spleen and lung homogenates of EMCV-infected mice.
  • Surprisingly, 2-5A synthesis was also observed in the serum of infected mice.
  • 2-5A synthesis was confirmed in the serum of mice treated with poly(I) x poly(C) or mouse fibroblast interferon.

Conclusions:

  • 2-5A synthesis occurs in vivo in mice during viral infection and interferon induction.
  • The presence of 2-5A in serum suggests systemic involvement of this pathway.
  • These findings extend the understanding of interferon-inducible enzyme activity to animal models.